As active pharmaceutical ingredients or drug substances become more targeted or potent, many of these compounds will fall into either a Category 4 or 5 control band.
Past News ReleasesRSS
Broomfield, CO (PRWEB) January 25, 2012
"Manufacturing Highly Potent Compounds - Understanding and Controlling the Risks" webinar, presented by Affygility Solutions premieres February 7th, 2012 at 10 am MST.
In Affygility Solutions newest webinar, the environmental, health, safety, and occupational toxicology professionals at Affygility Solutions will discuss key concepts, practices, and trends for handling highly potent compounds or drug substances. "As active pharmaceutical ingredients or drug substances become more targeted or potent, many of these compounds will fall into either a Category 4 or 5 control band," said Dean M. Calhoun, CEO of Affygility Solutions. "Companies handling Category 4 or 5 potent compounds must implement sophisticated engineering and administrative controls to prevent occupational exposure."
For more information and registration instructions for this webinar go to the "Manufacturing Highly Potent Compounds - Understanding and Controlling the Risks" page on the Affygility Solutions' website.
About Affygility Solutions
Affygility Solutions offers environmental, industrial hygiene, occupational safety, and occupational toxicology services to the biotechnology, pharmaceutical, and medical device industries. Our services include Affytrac: the leading EHS software system for the life science industry, online and offline training seminars, potent compound safety categorization, occupational exposure limits, occupational toxicology services, containment validation and surrogate monitoring, and much more. We have provided these services small, mid-size and large life science companies throughout the United States, Europe, and Asia.